Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs. Issue 10 (3rd October 2018) - Tampaki, Ekaterini Christina; Tampakis, Athanasios; Droeser, Raoul; Patsouris, Efstratios; Kouraklis, Gregory